Previous Article | Next Article ![]()
Applied and Environmental Microbiology, October 2007, p. 6313-6316, Vol. 73, No. 19
0099-2240/07/$08.00+0 doi:10.1128/AEM.00473-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
| SHORT REPORT |

Driss Elhanafi,
and
S. Kathariou*
North Carolina State University, Department of Food Science, Raleigh, North Carolina 27695
Received 1 March 2007/ Accepted 15 May 2007
|
|
|---|
|
|
|---|
Serotype 4b strains harbor specific decorations in the teichoic acid (TA) of the cell wall that are required for reactivity with monoclonal antibodies (MAbs) such as c74.22, specific for strains of serotypes 4b, 4d, and 4e (8). At least two loci (gtcA and the gltA-gltB gene cassette) are required for reactivity of the bacteria with c74.22 and TA glycosylation (11, 15). Furthermore, gtcA mutants are deficient in invasion of several mammalian cell lines (14) and appear to be impaired for virulence in intragastric murine models of listeriosis (N. Faith, C. Czuprynski, Y. Cheng, and S. Kathariou, unpublished results). A population-level survey of epidemic-associated strains from three listeriosis outbreaks revealed several naturally occurring c74.22-negative strains with deficiency in glycosylation of the TA of the cell wall and resistance to serotype 4b-specific phage (4). Such surface antigen variants may arise in the course of the infection, representing an immune system evasion strategy on the part of the pathogen. However, one cannot exclude the possibility that they arose in the food vehicle or during subsequent passages of the bacteria in the laboratory.
Although c74.22-negative strains can be generated by transposon mutagenesis in the laboratory (11, 15), their emergence under laboratory conditions has not yet been described. Furthermore, it is not known whether such variants can arise in strains of ECII, which were not recognized prior to the 1998-1999 hot dog outbreak. In this study, we identified and characterized such variants of ECI and ECII strains, which arose in the course of laboratory investigations of these strains.
In the course of investigations of a genomic region ("region 18") which is located immediately upstream of inlA-inlB and which has diverged in ECII strains (5), we constructed a mutant of the ECII strain H7550 which harbored a deletion of region 18 and was designated ECII
18R (3). The mutant was characterized by colony immunoblot assays with the MAb c74.22 described elsewhere (8). For these immunoblots bacteria were routinely grown in liquid, using as inoculum agar-grown cultures stored at 4°C. ECII
18R (later designated ECII
18RV) was found to be negative with MAb c74.22, whereas the parental strain H7550 reacted normally (Table 1; Fig. 1). However, when the –80°C stock culture of ECII
18R was examined, it was found to be c74.22 positive, suggesting that the c74.22-negative phenotype was not due to the deletion. The c74.22-negative variant ECII
18RV has remained negative with c74.22 in several repeated colony immunoblot tests (data not shown).
|
View this table: [in a new window] |
TABLE 1. Phage susceptibilities and c74.22 reactivities of strains investigated in this study
|
![]() View larger version (50K): [in a new window] |
FIG. 1. cis complementation of surface antigen expression of ECII 18RV with wild-type gltA-gltB. Overnight cultures were spotted on the nitrocellulose membrane in triplicate. From top to bottom are shown ECII 18R (positive control; deletion mutant derived from strain H7550), ECII 18RV (c74.22-negative variant of ECII 18R), ECII 18RV::pPLAB (ECII 18RV harboring pPLAB), and ECII 18RV::pPL2 (negative control; ECII 18RV harboring cloning vector).
|
An earlier study revealed that the c74.22-negative epidemic-associated strains were all resistant to serotype 4b-specific phage (4). To determine whether the ECII
18RV and F2381L-Phi-R variants may also have altered phage susceptibility profiles in comparison to their parental counterparts, infection and phage adsorption assays with the serotype 4b-specific phage A500 and the Listeria genus-specific phages A511 and
20422-1 (9, 12, 13) were carried out as described before (17). ECII
18RV was resistant to one of these phages,
20422-1, whereas its parental counterpart ECII
18R and the original wild-type strain H7550 were both susceptible (Table 1). F2381L-Phi-R was resistant to infection not only with
20422-1 but also with the serotype 4b-specific phage A500 and the Listeria genus-specific phage A511. In contrast, the original F2381L strain (stock culture preserved at –80°C) was susceptible to all three phages (Table 1). Thus, the phage susceptibility profiles of the two variants were different from those of their parental counterparts but also differed markedly from each other.
Phage resistance may reflect changes in the presence or accessibility of phage receptors (18) or other mechanisms subsequent to infection. Adsorption of phage
20422-1 onto F2381L-Phi-R and ECII
18RV was reduced 18.8-fold and 7.5-fold, respectively. Similar results were obtained with phage A511 and A500 adsorption onto F2381L-Phi-R (Table 2). These results suggest that loss of phage receptors accounted for the phage resistance of the variants. The receptors for phages A511 and A500 have been reported to be peptidoglycan and glycosylated TA, respectively (18). Thus, our findings that ECII
18RV was susceptible to A511 but resistant to
20422-1 suggest that these two Listeria genus-specific phages use different receptors for infection of the bacteria. Phage receptors that may be absent in F2381L-Phi-R are currently unidentified.
|
View this table: [in a new window] |
TABLE 2. Adsorption deficiency of phage-resistant variants
|
18RV and ECII
18R also had indistinguishable PFGE profiles with ApaI (Fig. 2B), as well as with AscI (data not shown).
![]() View larger version (89K): [in a new window] |
FIG. 2. PFGE profiles identical between c74.22-negative variants and their parental strains. (A) PFGE patterns of F2381L and F2381L-Phi-R generated by AscI (left) and ApaI (right). Lanes 1, F2381L (Strr derivative of F2381 [ECI]); lanes 2, F2381L-Phi-R (c74.22-negative laboratory variant of F2381L). (B) PFGE patterns of H7550, ECII 18R, and ECII 18RV generated by ApaI. Lane 1, H7550 (Listeria monocytogenes 4b wild type [ECII]); lane 2, ECII 18R (deletion mutant derived from strain H7550); lane 3, ECII 18RV (c74.22-negative laboratory variant of ECII 18R). Lanes M, lambda concatemers (48.5 to 727.5 kb; New England Biolabs) used as molecular size markers.
|
18RV as described previously (10). The resulting gtcA-complemented derivatives of F2381L-Phi-R and ECII
18RV were designated F2381L-Phi-R::pPL95 and ECII
18RV::pPL95, respectively. pPLAB harboring the gltA-gltB cassette was introduced into F2381L-Phi-R and ECII
18RV, resulting in F2381L-Phi-R::pPLAB and ECII
18RV::pPLAB, respectively. Partial restoration of reactivity with c74.22 was obtained in ECII
18RV harboring the integrated pPLAB, whereas ECII
18RV harboring the integrated pPL2 alone remained negative with this MAb (Fig. 1). Reactivity of F2381L-Phi-R with c74.22 was not recovered by either integrated pPL95 or pPLAB (Table 1). The lack of restoration of reactivity of F2381L-Phi-R with the cloned gtcA (pPL95) was not likely to involve impaired expression of the cloned gene. In studies with the gtcA transposon mutant M44 (15), we found that the gtcA construct used here (pPL95) fully restored c74.22 reactivity and phage susceptibility to this mutant (Y. Cheng and S. Kathariou, unpublished data). Furthermore, the gtcA sequence of F2381 is identical to that in strain 4b1, from which M44 was derived, suggesting that strain-specific sequence differences were not responsible for the lack of complementation in F2381L-Phi-R. The gltA-gltB cassette sequences (including the upstream region) cloned in pPLAB were identical between the strain used as template to amplify the cassette (H7550) and F2381 (data not shown). Taken together, the current data suggest that F2381L-Phi-R harbors a mutation in a currently unidentified gene (other than gtcA or the gltA-gltB cassette) required for reactivity with c74.22.
Phage sensitivity of F2381L-Phi-R to A500, A511, or
20422-1 was not restored by either integrated pPL95 or pPLAB. ECII
18RV also failed to recover phage susceptibility to
20422-1 with either integrated construct. Lack of restoration with the integrated pPLAB was surprising, since ECII
18RV with integrated pPLAB had partial complementation in reactivity with c74.22 (Table 1; Fig. 1). It is possible that the number of receptor determinants in the pPLAB-complemented variant was insufficient or that their presentation at the cell surface was suboptimal. However, we cannot exclude the possibility that this strain harbors more than one mutation.
The conditions leading to emergence and establishment of serotype 4b variants such as described here remain unidentified. Under certain laboratory conditions the variants may have enhanced fitness in comparison to their parental strains. The bacteria remained c74.22 negative following multiple laboratory passages and, in the case of F2381L-Phi-R, following independent construction of mutants harboring deletions in several different genes, suggesting that the c74.22-negative phenotype of the variants is stable under laboratory conditions.
The identification of these variants in both ECI and ECII strains suggests that they do not represent isolated, exceptional events. It is conceivable that similar variants can arise and become inadvertently established in other serotype 4b strains. The current findings suggest that great care should be exercised in characterization of serotype 4b strains and genetic constructs thereof. Phenotypic attributes of the spontaneous variants (phage resistance, lack of reactivity with c74.22, and possibly impact on pathogenicity) could be erroneously attributed to the loss of the gene of interest in deletion mutants and other constructs. It would, therefore, be important for researchers to monitor the existence of 4b-specific surface antigens to avoid complication of their findings by spontaneous loss of the antigens. In our opinion, phage susceptibility assays with phages such as
20422-1 would be an ideal way for laboratories to monitor maintenance of the 4b-specific antigens in their strains when 4b-specific MAbs such as c74.22 are not available.
We thank R. Calendar for A500 and pPL2 and M. Loessner for the gift of A511. We thank R. M. Siletzky for assistance with PFGE and Jae-Won Kim for providing us with purified phages for use in this work. We appreciate the encouragement and support of all other members of our laboratory.
Published ahead of print on 3 August 2007. ![]()
Present address: Dermatology Research, Veterans Affairs Medical Center, San Francisco, CA 94121. ![]()
Present address: North Carolina State University, Biomanufacturing Training and Education Center, Raleigh, NC. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»